Prevention of chemotherapy-induced neutropenia by special honey intake

Medical Oncology

Volumn 23, Issue 4, 2006, Pages 549-552

  Zidan, Jamal ^a,b   Shetver, Lika ^a   Gershuny, Anthony ^c,d   Abzah, Amira ^a   Tamam, Sigalit ^a   Stein, Moshe ^a   Friedman, Eitan ^e  

^a Rebecca Sieff Government Hospital   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c OLDCHURCH HOSPITAL   (United Kingdom)

^d RAMBAM MEDICAL CENTER   (Israel)

^e SHEBA MEDICAL CENTER   (Israel)

Author keywords

Cancer patients; Chemotherapy; Hematologic toxicity; Honey

Indexed keywords

CARBOPLATIN; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; EXPRESS HONEY; FLUOROURACIL; GEMCITABINE; HEMOGLOBIN; IRINOTECAN; NAVELBINE; NUTRACEUTICAL; PACLITAXEL; PREDNISONE; UNCLASSIFIED DRUG; VINCRISTINE SULFATE;

ABSENCE OF SIDE EFFECTS; ADULT; AGED; ARTICLE; BLOOD CELL COUNT; CANCER CHEMOTHERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG INDUCED DISEASE; FEMALE; HEMOGLOBIN BLOOD LEVEL; HIGH RISK PATIENT; HONEY; HUMAN; LYMPHOMA; MALE; METASTASIS; NEUTROPENIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RECURRENT DISEASE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; COLONY-STIMULATING FACTORS; FEMALE; HONEY; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; NEUTROPENIA;

EID: 33846959516     PISSN: 13570560     EISSN: None     Source Type: Journal    
DOI: 10.1385/MO:23:4:549     Document Type: Article

References (10)

1. Ozer H, et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 2000;18:3558-3585.
2. Blay JY, et al. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol 1996;14:636-643.
3. Infectious Disease Society of America. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin Infect Dis 2002; 34:730-751.
4. Phillips K, Tannock IF. Design and interpretation of clinical trails that evaluate agents that may offer protection from the toxic effects of cancer chemotherapy. J Clin Oncol 1998;16:3179-3190.
5. Bokemeyer C, et al. Hematopoietic growth factors and treatment of testicular cancer: Biological interactions, routine use and dose-intensive chemotherapy. Ann Hematol 1996;72:1-9.
6. Zidan J, et al. Prevention of chemotherapy induced pancytopenia by special honey intake. 16th International Congress on Anti-Cancer Treatment. Paris, February 1st-4th, 2005. Poster, p:349.
7. White IW Jr. Honey. Adv Food Res 1978;24:288-374.
8. Kukagawa K, Kunugi A, Kurechi T. Chemistry and implications of degradation of phenolic antioxidants in food antioxidant. Elsevier: New York, 1990.
9. Rosenblat G, Angonnet S, Goroshit A, Tabak M, Neeman I. Antioxidant properties of honey produced by bees fed with medical plant extracts. International Conference on: Bee Products: Properties, Applications and Aitherapy. Tel-Aviv, Israel. May 26-30, 1996.
10. Bermond P. Biological effects of food antioxidants. In: Hudson BJF (ed), Food antioxidants, Elsevier Science Publishing Co. Inc: NY. 1990, pp: 193-251.